— Know what they know.
Not Investment Advice

PETQ NASDAQ

PetIQ, Inc.
1W: +0.2% 1M: +0.8% 3M: +43.4% 1Y: +65.0% 3Y: +25.9% 5Y: +21.2%
$30.98
Last traded 2024-10-25 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $919.2M mcap · 24M float · 3.87% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.1B +19.6% ▲
5Y CAGR: +15.8%
Gross Profit
$253M +20.5% ▲
5Y CAGR: +24.9%
Operating Income
$60M +120.4% ▲
5Y CAGR: +50.6%
Net Income
$2M +104.4% ▲
EPS (Diluted)
$0.07 +104.3% ▲
EBITDA
$81M +547.3% ▲
5Y CAGR: +32.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$709M$780M$933M$922M$1.1B
YoY Growth+34.2%+10.0%+19.5%-1.2%+19.6%
Cost of Revenue$602M$645M$746M$712M$849M
Gross Profit$107M$135M$186M$210M$253M
Gross Margin15.1%17.3%20.0%22.8%22.9%
R&D Expenses$1M$2M$8M$2M$1M
SG&A Expenses$91M$116M$158M$183M$192M
Operating Expenses$103M$138M$171M$183M$193M
Operating Income$4M-$3M$16M$27M$60M
Operating Margin0.6%-0.3%1.7%3.0%5.4%
Interest Expense$14M$23M$25M$27M$35M
Income Before Tax-$18M-$29M-$13M-$47M$2M
Tax Expense-$3M$52M$4M$1M-$173K
Net Income-$14M-$81M-$16M-$49M$2M
Net Margin-2.0%-10.4%-1.8%-5.3%0.2%
EPS (Diluted)$-0.63$-3.29$-0.58$-1.67$0.07
EBITDA$12M$22M$49M$13M$81M
Shares Outstanding23M25M28M29M30M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms